The United States has launched a criminal prosecution against ten individuals from the pharmaceutical sector, accused of selling over 70 million illegal opioid pills valued at approximately $1.3 billion.
This case stands out as the most critical legal action ever taken against individuals involved in the unlawful distribution and manufacturing of drugs.
These proceedings originate from an extensive investigation that exposed the illegal production and subsequent distribution of a large quantity of drugs, primarily opioid pills.
The defendants, comprising business professionals and brokers, unlawfully manufactured these pills and then sold them on the black market, earning millions in the process.
This legal action reflects the government’s commitment to combating the opioid epidemic and holding those responsible accountable.
